{
  "entities": [
    {
      "id": "E1",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e1a1d6173ec99114458b231455259259"
      ],
      "confidence": 0.95,
      "evidence": "Drug addiction can be defined as a chronically relapsing disorder",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e1a1d6173ec99114458b231455259259"
      ],
      "confidence": 0.9,
      "evidence": "the term addiction is now encompassed by the term substance use disorders",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "dysphoria",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "e1a1d6173ec99114458b231455259259"
      ],
      "confidence": 0.8,
      "evidence": "dysphoria, anxiety, irritability",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "anxiety",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "e1a1d6173ec99114458b231455259259"
      ],
      "confidence": 0.8,
      "evidence": "dysphoria, anxiety, irritability",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "irritability",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "e1a1d6173ec99114458b231455259259"
      ],
      "confidence": 0.8,
      "evidence": "dysphoria, anxiety, irritability",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "brain reward systems",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.9,
      "evidence": "Drugs of abuse activate brain reward systems",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "mesocorticostriatal dopamine systems",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.85,
      "evidence": "ascending mesocorticostriatal dopamine systems",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "ventral striatum",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.9,
      "evidence": "release dopamine and opioid peptides into the ventral striatum",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dopamine D1 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.9,
      "evidence": "low-affinity dopamine D1 receptors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "dopamine D2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.9,
      "evidence": "high-affinity dopamine D2 receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "reward",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.85,
      "evidence": "Reward is defined herein as any event that increases the probability of a response with a positive hedonic component",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "high",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.8,
      "evidence": "subjective sensation of the so-called high",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "conditioned responses",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.75,
      "evidence": "triggering conditioned responses",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.9,
      "evidence": "research on drug addiction",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.95,
      "evidence": "release dopamine",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "opioid peptides",
      "attributes": {},
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "confidence": 0.85,
      "evidence": "opioid peptides",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain_region"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "ventral tegmental area",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain_region"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "nucleus accumbens",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "endocannabinoid systems",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.85,
      "evidence": "endocannabinoid systems",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "proper inhibitory control and decision making",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.8,
      "evidence": "proper inhibitory control and decision making",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "normal functioning of reward, motivation, stress, and memory circuits",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.8,
      "evidence": "normal functioning of reward, motivation, stress, and memory circuits",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "mood regulation circuits",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.75,
      "evidence": "circuits that are involved in mood regulation",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "stress reactivity circuit",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.75,
      "evidence": "stress reactivity (which involves the amygdala, hypothalamus, and habenula)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "interoception circuit",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.75,
      "evidence": "interoception (which involves the insula and anterior cingulate cortex)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "awareness of negative emotional states",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.7,
      "evidence": "awareness of negative emotional states",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "executive function circuits",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.8,
      "evidence": "executive function circuits",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "motivational circuits",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.8,
      "evidence": "motivational circuits",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "stress circuits",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.8,
      "evidence": "stress circuits",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "neurotransmitter-specific neuroplasticity circuits",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.75,
      "evidence": "neurotransmitter-specific neuroplasticity circuits",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Compound",
      "name": "dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "dopamine",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "enkephalins",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "enkephalins",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "glutamate",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "glutamate",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "gamma-aminobutyric acid",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "norepinephrine",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "norepinephrine",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Compound",
      "name": "corticotropin-releasing factor",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "corticotropin-releasing factor (CRF)",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Compound",
      "name": "dynorphin",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "dynorphin",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Compound",
      "name": "neuropeptide Y",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "neuropeptide Y",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Compound",
      "name": "endocannabinoids",
      "attributes": {},
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "confidence": 0.9,
      "evidence": "endocannabinoids",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "NMDA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.9,
      "evidence": "N-methyl-D-aspartate (NMDA) receptors",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "AMPA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.9,
      "evidence": "\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "glutamatergic projections",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.8,
      "evidence": "glutamatergic projections",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.85,
      "evidence": "prefrontal cortex",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.85,
      "evidence": "amygdala",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.85,
      "evidence": "ventral tegmental area",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "confidence": 0.85,
      "evidence": "nucleus accumbens",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "dopamine signalling",
      "attributes": {
        "target_type": "signalling pathway"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "drive dopamine signalling",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "impairments in executive function mediated by the prefrontal cortex",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "tonic dopamine cell firing",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "changes in tonic dopamine cell firing",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dopamine projections to the prefrontal cortex",
      "attributes": {
        "target_type": "neural pathway"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "dopamine projections to the prefrontal cortex",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "D1 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.9,
      "evidence": "lower-affinity D1 receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "cAMP signalling",
      "attributes": {
        "target_type": "signalling pathway"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "stimulate cyclic adenosine monophosphate (cAMP) signalling",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "D2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.9,
      "evidence": "D2 receptors",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "D3 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.9,
      "evidence": "D3 receptors",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "co-localise in the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "augments progression through the addiction cycle",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "augments progression through the addiction cycle",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "intense desire for the drug (craving)",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "intense desire for the drug (ie, craving)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "compulsive use",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "compulsive use",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "maintain motivation to take the drug",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "maintain motivation to take the drug",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "impairments in executive function",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "impairments in executive function",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "lower but more stable dopamine levels",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "lower but more stable dopamine levels",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "spikes in dopamine release",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.8,
      "evidence": "spikes in dopamine release",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "drug-seeking behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.85,
      "evidence": "associated with drug-seeking behaviour",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "confidence": 0.9,
      "evidence": "individuals with addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "dopaminergic transmission",
      "attributes": {
        "target_type": "neurotransmitter system"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.8,
      "evidence": "decreases in dopaminergic transmission",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "serotonergic transmission",
      "attributes": {
        "target_type": "neurotransmitter system"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.8,
      "evidence": "decreases in serotonergic transmission",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "nucleus accumbens",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.9,
      "evidence": "nucleus accumbens",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "striatal dopamine responses",
      "attributes": {
        "target_type": "neurochemical response"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.85,
      "evidence": "amphetamine-induced or methylphenidate-induced striatal dopamine responses",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "\u03bc opioid receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.9,
      "evidence": "increases in \u03bc opioid receptor",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreased dopaminergic transmission",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.75,
      "evidence": "decreases in dopaminergic transmission",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreased serotonergic transmission",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.75,
      "evidence": "decreases in serotonergic transmission",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "lower striatal dopamine responses",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.8,
      "evidence": "striatal dopamine responses are 50% lower",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "lower self-reports of rewarding effects",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.85,
      "evidence": "lower self-reports of the drug\u2019s rewarding effects",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "increased \u03bc opioid receptor",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.8,
      "evidence": "increases in \u03bc opioid receptor",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Condition",
      "name": "drug withdrawal",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.9,
      "evidence": "drug withdrawal",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Evidence",
      "name": "in-vivo microdialysis",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.85,
      "evidence": "in-vivo microdialysis in rats",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Evidence",
      "name": "brain imaging studies",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "confidence": 0.85,
      "evidence": "brain imaging studies in humans",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "GABAergic transmission",
      "attributes": {
        "target_type": "neurotransmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.8,
      "evidence": "decreases in GABAergic",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "NMDA glutamatergic transmission",
      "attributes": {
        "target_type": "neurotransmission"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.8,
      "evidence": "increases in NMDA glutamatergic transmission",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "nicotinic receptor function",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.85,
      "evidence": "Differential regional changes in nicotinic receptor function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "\u03b14\u03b22 nicotinic receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.9,
      "evidence": "implicating \u03b14\u03b22 nicotinic receptor subtypes",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "opioid withdrawal",
      "attributes": {
        "condition_type": "withdrawal"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.9,
      "evidence": "responsivity during opioid withdrawal",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "acute withdrawal",
      "attributes": {
        "condition_type": "withdrawal"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.85,
      "evidence": "clinical syndrome of acute withdrawal",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "protracted abstinence",
      "attributes": {
        "condition_type": "abstinence"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.85,
      "evidence": "protracted abstinence",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "loss of interest in normal rewards",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.8,
      "evidence": "loss of interest in normal, non-drug rewards",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "decreased reward system function",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.85,
      "evidence": "decreases in reward system function",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "long-term biochemical changes",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "confidence": 0.8,
      "evidence": "long-term biochemical changes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CRF",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.9,
      "evidence": "CRF are dysregulated",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "CRF receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.85,
      "evidence": "CRF receptor antagonists block",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "kappa opioid receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.9,
      "evidence": "kappa opioid receptor antagonists",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "dynorphin",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.85,
      "evidence": "dynorphin, are recruited",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.9,
      "evidence": "Decreases in the release of dopamine",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "withdrawal",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.95,
      "evidence": "withdrawal/negative affect stage",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "negative emotional states",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.9,
      "evidence": "negative emotional states in withdrawal",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "anxiety-like effects",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.85,
      "evidence": "anxiety-like, stress-like effects",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "compulsive drug seeking",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.9,
      "evidence": "compulsive drug seeking in animals",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "dysregulation of brain stress systems",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.8,
      "evidence": "brain stress systems are recruited",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "decreased dopamine release",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "confidence": 0.85,
      "evidence": "Decreases in the release of dopamine",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "lateral habenula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.9,
      "evidence": "lateral habenula plays a key role",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.85,
      "evidence": "decreases in dopamine neuron firing in the ventral tegmental area",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "alpha 5 nicotinic acetylcholine receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.9,
      "evidence": "alpha 5 nicotinic acetylcholine receptors in the habenula",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "alpha 2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.8,
      "evidence": "habenular alpha 2 receptors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "mediating and encoding aversive states",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.85,
      "evidence": "mediating and encoding aversive states",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "decreases in dopamine neuron firing",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.8,
      "evidence": "decreases in dopamine neuron firing",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "modulate aversive responses",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.75,
      "evidence": "modulate aversive responses to large doses of nicotine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "nicotine withdrawal",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "confidence": 0.7,
      "evidence": "nicotine withdrawal",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "reward function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.8,
      "evidence": "decreases in reward function",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "stress function",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.8,
      "evidence": "increases in stress function",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "motivational circuits",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.75,
      "evidence": "motivational circuits of the ventral striatum",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "ventral striatum",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.9,
      "evidence": "ventral striatum",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "extended amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.9,
      "evidence": "extended amygdala",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "habenula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.9,
      "evidence": "habenula",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "negative reinforcement",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.85,
      "evidence": "trigger of negative reinforcement",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "compulsive drug-seeking behaviour",
      "attributes": {
        "condition_type": "behavioral disorder"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.8,
      "evidence": "compulsive drug-seeking behaviour",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.9,
      "evidence": "addiction",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "dynorphin system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.8,
      "evidence": "dynorphin system in the ventral striatum",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "dopamine neuron firing",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.8,
      "evidence": "decrease dopamine neuron firing",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "CRF",
      "attributes": {
        "target_type": "protein"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.85,
      "evidence": "recruitment of CRF in the amygdala",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "extrahypothalamic stress systems",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "confidence": 0.75,
      "evidence": "extrahypothalamic stress systems",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "neuropeptide Y",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.9,
      "evidence": "neuropeptide Y",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "nociceptin",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.9,
      "evidence": "nociceptin",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "endocannabinoids",
      "attributes": {
        "target_type": "endogenous ligand"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.9,
      "evidence": "endocannabinoids",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "endocannabinoid system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.85,
      "evidence": "endocannabinoid system",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "cannabinoid CB1 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.9,
      "evidence": "cannabinoid CB1 receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.95,
      "evidence": "vulnerability to the development and perpetuation of addiction",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "stress",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.9,
      "evidence": "brain stress systems",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "buffer brain stress systems",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.85,
      "evidence": "buffer the brain stress systems",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "influence vulnerability to addiction",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.8,
      "evidence": "influence vulnerability to the development and perpetuation of addiction",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "modulate response to stress",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.85,
      "evidence": "modulates the response of the brain to stress",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "enhanced stress reactivity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.8,
      "evidence": "enhanced stress reactivity in addiction",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "reductions of cannabinoid CB1 receptors",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.85,
      "evidence": "reductions of cannabinoid CB1 receptors",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "enduring aversive emotional states",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.8,
      "evidence": "enduring aversive emotional states",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "chronic relapse",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "confidence": 0.85,
      "evidence": "chronic relapse",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.9,
      "evidence": "prefrontal cortex",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "prelimbic cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.85,
      "evidence": "prelimbic cortex",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "infralimbic cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.8,
      "evidence": "infralimbic cortex",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "mesocortical dopamine neurons",
      "attributes": {
        "target_type": "neuron"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.85,
      "evidence": "mesocortical dopamine neurons",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.9,
      "evidence": "ventral tegmental area",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "executive control over incentive salience",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.8,
      "evidence": "Executive control over incentive salience",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "maintain goal-directed behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.85,
      "evidence": "maintain goal-directed behaviour",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "flexibility of stimulus\u2013response associations",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.8,
      "evidence": "flexibility of stimulus\u2013response associations",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "excitatory control over dopamine cell firing",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.85,
      "evidence": "excitatory control over dopamine cell firing",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "dopamine release in the prefrontal cortex",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "confidence": 0.85,
      "evidence": "dopamine release in the prefrontal cortex",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Evidence",
      "name": "rodent studies",
      "attributes": {
        "evidence_level": 2
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.9,
      "evidence": "Evidence from rodent studies",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "prelimbic prefrontal cortex to ventral striatum circuit",
      "attributes": {
        "target_type": "circuit"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.85,
      "evidence": "circuit that links the prelimbic prefrontal cortex to the ventral striatum",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "glutamatergic projection from prelimbic prefrontal cortex to nucleus accumbens",
      "attributes": {
        "target_type": "projection"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "glutamatergic projection from the prelimbic prefrontal cortex to the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "D_1 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.85,
      "evidence": "D_1 and D_2 receptors in the frontal cortex",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "D_2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.85,
      "evidence": "D_1 and D_2 receptors in the frontal cortex",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "glutamatergic projection from prelimbic prefrontal cortex, basolateral amygdala, and ventral subiculum to nucleus accumbens",
      "attributes": {
        "target_type": "projection"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.75,
      "evidence": "glutamatergic projection from the prelimbic prefrontal cortex, basolateral amygdala, and ventral subiculum to the nucleus accumbens",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "CRF",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "activation of both CRF and norepinephrine",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "norepinephrine",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "activation of both CRF and norepinephrine",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "extended amygdala",
      "attributes": {
        "target_type": "region"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.75,
      "evidence": "elements of the extended amygdala",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "ventral tegmental area",
      "attributes": {
        "target_type": "region"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "ventral tegmental area",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "prefrontal glutamatergic system",
      "attributes": {
        "target_type": "system"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "increases in activity of the prefrontal glutamatergic system",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "drug-induced reinstatement",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.9,
      "evidence": "drug-induced reinstatement",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "cue-induced reinstatement",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.85,
      "evidence": "cue-induced reinstatement",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "stress-induced reinstatement",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.85,
      "evidence": "stress-induced reinstatement",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "protracted abstinence",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.8,
      "evidence": "protracted abstinence",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "craving-like responses",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "confidence": 0.75,
      "evidence": "craving-like responses",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "confidence": 0.9,
      "evidence": "frontal cortex-derived executive function disorders in addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "excessive salience to drug-paired cues",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "confidence": 0.85,
      "evidence": "excessive salience to drug-paired cues",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "decreases in responsiveness to non-drug rewards",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "confidence": 0.85,
      "evidence": "decreases in the responsiveness to non-drug rewards",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreases in ability to inhibit maladaptive behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "confidence": 0.85,
      "evidence": "decreases in the ability to inhibit maladaptive behaviour",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "frontal cortex-derived executive function disorders",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "confidence": 0.8,
      "evidence": "frontal cortex-derived executive function disorders",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "middle insular function",
      "attributes": {
        "target_type": "brain region function"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.85,
      "evidence": "Cravings for food, cocaine, and nicotine are also related to middle insular function",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "cravings",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.9,
      "evidence": "Cravings for food, cocaine, and nicotine",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.8,
      "evidence": "without experiencing cravings or relapse",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "insula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.95,
      "evidence": "Tobacco smokers with damage to the insula",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "ventromedial prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.9,
      "evidence": "ventromedial prefrontal cortex and insula are necessary components",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "interoceptive function",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.85,
      "evidence": "The insula appears to have an interoceptive function",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "conscious awareness of urges",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.8,
      "evidence": "providing conscious awareness of these urges",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "differential activation during craving",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.75,
      "evidence": "differential activation of the insula during craving",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "CRF",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.7,
      "evidence": "hypothesised to involve CRF activation",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reactivity as biomarker for relapse prediction",
      "attributes": {
        "level": "systemic",
        "valence": "neutral",
        "verification_needed": true
      },
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "confidence": 0.65,
      "evidence": "reactivity of this brain region has been suggested to serve as a biomarker to help predict relapse",
      "verified": false
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "D2 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.9,
      "evidence": "D2 receptor availability",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.95,
      "evidence": "vulnerability to addiction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "reduced D2 receptor availability",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.85,
      "evidence": "reductions of D2 receptor availability",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "decreased baseline glucose metabolism",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.8,
      "evidence": "decreases in baseline glucose metabolism",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "impulsivity",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.75,
      "evidence": "impulsivity in methamphetamine abusers",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "compulsive cocaine administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.75,
      "evidence": "compulsive cocaine administration",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "methamphetamine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.85,
      "evidence": "Methamphetamine-dependent individuals",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "better treatment outcomes",
      "attributes": {
        "level": "systemic",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "confidence": 0.8,
      "evidence": "better treatment outcomes",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP formation",
      "attributes": {
        "target_type": "signaling pathway"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.8,
      "evidence": "upregulates cAMP formation",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PKA activity",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.8,
      "evidence": "cAMP-dependent protein kinase A (PKA) activity",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PKA-dependent protein phosphorylation",
      "attributes": {
        "target_type": "cellular process"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.8,
      "evidence": "PKA-dependent protein phosphorylation",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "nucleus accumbens cAMP/PKA signalling",
      "attributes": {
        "target_type": "signaling pathway"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.85,
      "evidence": "nucleus accumbens cAMP/PKA signalling",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Gs/cAMP/PKA signalling pathway",
      "attributes": {
        "target_type": "signaling pathway"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.85,
      "evidence": "Gs/cAMP/PKA signalling pathway",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.9,
      "evidence": "addicted state",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "neuroplastic changes",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.75,
      "evidence": "neuroplastic changes",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "molecular and cellular adaptations",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.75,
      "evidence": "molecular and cellular adaptations",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "signal transduction mechanisms",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.7,
      "evidence": "signal transduction mechanisms",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "changes in gene transcription",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.7,
      "evidence": "changes in gene transcription",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "escalations in drug self-administration",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.8,
      "evidence": "escalations in drug self-administration",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "compulsive-like drug-seeking behaviour",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.8,
      "evidence": "compulsive-like drug-seeking behaviour",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "critical neuroadaptation",
      "attributes": {
        "level": "cellular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "confidence": 0.75,
      "evidence": "critical neuroadaptation",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "cAMP response element binding protein",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.9,
      "evidence": "cAMP response element binding protein",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "decreases reinforcing value of rewards",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.85,
      "evidence": "decreases the reinforcing value of natural and drug rewards",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "withdrawal/negative affect stage-related decreases in reward pathway function",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.8,
      "evidence": "withdrawal/negative affect stage-related decreases in reward pathway function",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "amotivational state",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.75,
      "evidence": "amotivational state",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "dysphoric state",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.75,
      "evidence": "dysphoric state",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "depressed-like state",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.8,
      "evidence": "depressed-like state",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "anxiety-like behaviours",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.85,
      "evidence": "anxiety-like behaviours",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "increases susceptibility to negative emotional states",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "confidence": 0.8,
      "evidence": "increases susceptibility to negative emotional states",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "\u0394FosB",
      "attributes": {
        "target_type": "transcription factor"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.9,
      "evidence": "accumulating levels of \u0394FosB",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Effect",
      "name": "exaggerated sensitivity to rewarding effects of drugs",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.85,
      "evidence": "exaggerated sensitivity to the rewarding effects of drugs of abuse",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.9,
      "evidence": "helps initiate and maintain a state of addiction",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "histone modifications",
      "attributes": {
        "target_type": "epigenetic modification"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.8,
      "evidence": "histone modifications that act in a combinational fashion",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "altered pre-mRNA splicing",
      "attributes": {
        "level": "molecular",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.85,
      "evidence": "strikingly alter pre-mRNA splicing",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "cocaine-induced conditioned place preference",
      "attributes": {
        "condition_type": "behavioral response"
      },
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "confidence": 0.9,
      "evidence": "cocaine-induced conditioned place preference",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "AMPA-type glutamate receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.9,
      "evidence": "AMPA-type glutamate receptors are recruited",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "calcium-permeable AMPA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.85,
      "evidence": "recruits calcium-permeable AMPA receptors",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "non-calcium-permeable AMPA receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.85,
      "evidence": "recruits non-calcium-permeable AMPA receptors",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "metabotropic glutamate 1 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.9,
      "evidence": "blockade of metabotropic glutamate 1 receptors",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "cue-induced incubation reinstatement",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.8,
      "evidence": "cue-induced incubation reinstatement",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "cocaine-primed reinstatement",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.8,
      "evidence": "cocaine-primed reinstatement",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "blockade",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "confidence": 0.75,
      "evidence": "blockade of metabotropic glutamate 1 receptors",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "mTORC1",
      "attributes": {
        "target_type": "kinase complex"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.95,
      "evidence": "mTORC1 belongs to the phosphoinositide 3-kinase",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PI3K-related kinase family",
      "attributes": {
        "target_type": "kinase family"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.85,
      "evidence": "belongs to the phosphoinositide 3-kinase (PI3K)-related kinase (PIKK) family",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Effect",
      "name": "dendritic translation of synaptic proteins",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.9,
      "evidence": "plays a key role in the dendritic translation of synaptic proteins",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "learning and memory",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.85,
      "evidence": "plays a major role in the molecular mechanisms associated with learning and memory",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "epilepsy",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.9,
      "evidence": "involved in several brain disorders, including epilepsy",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Condition",
      "name": "Parkinson's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.9,
      "evidence": "involved in several brain disorders, including Parkinson's disease",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "Alzheimer's disease",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.9,
      "evidence": "involved in several brain disorders, including Alzheimer's disease",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.9,
      "evidence": "involved in several brain disorders, including addiction",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "activation by drug and alcohol cues",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.8,
      "evidence": "Exposure to drug and alcohol cues activates the mTORC1 pathway",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "blockade of reconsolidation of cocaine memories",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.85,
      "evidence": "blockade of the mTORC1 pathway systemically blocked the reconsolidation of cocaine memories",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "blockade of reconsolidation of alcohol memories",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.85,
      "evidence": "blockade of mTORC1 in the amygdala blocked the reconsolidation of alcohol memories",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Condition",
      "name": "relapse",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "confidence": 0.8,
      "evidence": "potential molecular target for the treatment of relapse",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "addictions",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.95,
      "evidence": "Heritability of addictions is 40\u201360%",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "dopamine D1 receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.9,
      "evidence": "dopamine D1 receptor knockout rats",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "\u03bc opioid receptor",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.9,
      "evidence": "\u03bc opioid receptor knockout mice",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "\u03b14 nicotinic receptor subunit",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.85,
      "evidence": "\u03b14 nicotinic receptor subunit",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "\u03b15 nicotinic receptor subunit",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.85,
      "evidence": "\u03b15 nicotinic receptor subunit",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "AMPA-selective glutamate receptors (CNIH3)",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.8,
      "evidence": "AMPA-selective glutamate receptors (CNIH3)",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Condition",
      "name": "nicotine dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.9,
      "evidence": "vulnerability to nicotine dependence",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "opioid dependence",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "confidence": 0.9,
      "evidence": "opioid dependence",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "alcohol dehydrogenase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.9,
      "evidence": "alcohol dehydrogenase (ADH1B)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "acetaldehyde dehydrogenase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.9,
      "evidence": "acetaldehyde dehydrogenase (ALDH2)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "alcoholism",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.95,
      "evidence": "protective against alcoholism",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "aldehyde dehydrogenase 1a1",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.9,
      "evidence": "aldehyde dehydrogenase 1a1 (ALDH1a1)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Condition",
      "name": "alcohol consumption",
      "attributes": {
        "condition_type": "behavior"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.85,
      "evidence": "enhanced alcohol consumption",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "cytochrome P450 2A6",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.9,
      "evidence": "cytochrome P450 2A6",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "cytochrome P450 2D6",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.9,
      "evidence": "cytochrome P450 2D6",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "nicotine addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "confidence": 0.95,
      "evidence": "protective against nicotine addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "CRF1 receptor gene (CRHR1)",
      "attributes": {
        "target_type": "gene"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.9,
      "evidence": "CRF1 receptor gene (CRHR1)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "binge drinking",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.85,
      "evidence": "binge drinking in adolescents",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "excessive drinking",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.85,
      "evidence": "excessive drinking in adults",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "heavy drinking",
      "attributes": {
        "condition_type": "behavioral"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.85,
      "evidence": "heavy drinking in relation to stressful life events",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Study 163",
      "attributes": {
        "year": "163",
        "design": "genetic association study"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.8,
      "evidence": "two single-nucleotide polymorphisms...associated with binge drinking...163",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Study",
      "name": "Study 164",
      "attributes": {
        "year": "164",
        "design": "genetic association study"
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.8,
      "evidence": "homozygosity...associated with heavy drinking...164",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Evidence",
      "name": "genetic association evidence",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "confidence": 0.75,
      "evidence": "single-nucleotide polymorphisms...associated with",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "fatty acid amide hydrolase",
      "attributes": {
        "target_type": "enzyme"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.95,
      "evidence": "fatty acid amide hydrolase",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "C385A [Pro129Thr]",
      "attributes": {
        "target_type": "genetic mutation"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.9,
      "evidence": "C385A [Pro129Thr]",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "rs324420",
      "attributes": {
        "target_type": "genetic variant"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.9,
      "evidence": "rs324420",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Effect",
      "name": "reduction of fatty acid amide hydrolase expression",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.85,
      "evidence": "reduction of fatty acid amide hydrolase expression",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Effect",
      "name": "enhanced fronto-amygdala connectivity",
      "attributes": {
        "level": "cellular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.8,
      "evidence": "enhanced fronto-amygdala connectivity",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Effect",
      "name": "fear extinction learning",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.8,
      "evidence": "fear extinction learning",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Effect",
      "name": "decreased anxiety-like behaviours",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.85,
      "evidence": "decreased anxiety-like behaviours",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Condition",
      "name": "anxiety",
      "attributes": {
        "condition_type": "symptom"
      },
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "confidence": 0.9,
      "evidence": "anxiety-like behaviours",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "pathological gambling",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.9,
      "evidence": "pathological gambling",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Condition",
      "name": "binge-eating disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.9,
      "evidence": "binge-eating disorder",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Condition",
      "name": "compulsive buying",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.9,
      "evidence": "compulsive buying",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "internet addiction disorder",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.9,
      "evidence": "internet addiction disorder",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "striatal dopamine D2 receptors",
      "attributes": {
        "target_type": "receptor"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.85,
      "evidence": "striatal dopamine D2 receptors",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "prefrontal cortices",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.8,
      "evidence": "prefrontal cortices",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Go craving system",
      "attributes": {
        "target_type": "neural system"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.75,
      "evidence": "Go craving system",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "Stop inhibition systems",
      "attributes": {
        "target_type": "neural system"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.75,
      "evidence": "Stop inhibition systems",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "stress axis",
      "attributes": {
        "target_type": "physiological system"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.7,
      "evidence": "stress axis",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "reward deficits",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.8,
      "evidence": "reward deficits",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "stress sensitisation",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.8,
      "evidence": "stress sensitisation",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "impaired inhibitory control",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.8,
      "evidence": "impaired inhibitory control",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "reduced activity in prefrontal cortices",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.75,
      "evidence": "reduced activity in prefrontal cortices",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "deficits in the Go craving system",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.7,
      "evidence": "deficits in the Go craving system",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "deficits in Stop inhibition systems",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.7,
      "evidence": "deficits in Stop inhibition systems",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "dysregulation of the stress axis",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "confidence": 0.7,
      "evidence": "dysregulation of the stress axis",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "substance use disorders",
      "attributes": {
        "condition_type": "disease"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.95,
      "evidence": "Substance use disorders are complex",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "basal ganglia",
      "attributes": {
        "target_type": "neurocircuit"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.85,
      "evidence": "basal ganglia-driven binge/intoxication stage",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "extended amygdala",
      "attributes": {
        "target_type": "neurocircuit"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.85,
      "evidence": "extended amygdala-driven withdrawal/negative affect stage",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "prefrontal cortex",
      "attributes": {
        "target_type": "neurocircuit"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.85,
      "evidence": "prefrontal cortex-driven preoccupation/anticipation stage",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "ascending mesocorticolimbic dopamine system",
      "attributes": {
        "target_type": "neurotransmitter system"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "ascending mesocorticolimbic dopamine system",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "corticotropin-releasing factor",
      "attributes": {
        "target_type": "neuromodulator"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "corticotropin-releasing factor in the central nucleus",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "corticostriatal glutamate projections",
      "attributes": {
        "target_type": "neurotransmitter system"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "corticostriatal glutamate projections",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Effect",
      "name": "incentive salience",
      "attributes": {
        "level": "behavioral",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "gain incentive salience and promoting habit formation",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "habit formation",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "promoting habit formation that fosters excessive drug seeking",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Effect",
      "name": "excessive drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "fosters excessive drug seeking",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Effect",
      "name": "increases in dopamine neurotransmission",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "increases in dopamine and glutamate neurotransmission",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Effect",
      "name": "increases in glutamate neurotransmission",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "increases in dopamine and glutamate neurotransmission",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Effect",
      "name": "diminished reward function",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "diminish reward function via dopamine and opioid peptide deficits",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Effect",
      "name": "increased brain stress system activity",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "increased brain stress system activity",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Effect",
      "name": "deficits in executive function",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "deficits in executive function via dysregulation",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "dysregulation of glutamatergic networks",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "dysregulation of glutamatergic, GABAergic, and dopaminergic networks",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "dysregulation of GABAergic networks",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "dysregulation of glutamatergic, GABAergic, and dopaminergic networks",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Effect",
      "name": "dysregulation of dopaminergic networks",
      "attributes": {
        "level": "cellular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.75,
      "evidence": "dysregulation of glutamatergic, GABAergic, and dopaminergic networks",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "compulsive drug use",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "induce compulsive drug use",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "pathological drug seeking",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.8,
      "evidence": "drive pathological drug seeking",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Target",
      "name": "dynorphin",
      "attributes": {
        "target_type": "neuromodulator"
      },
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "confidence": 0.7,
      "evidence": "engagement of corticotropin-releasing factor and dynorphin",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Condition",
      "name": "drug addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.95,
      "evidence": "neurocircuitry of drug addiction",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "neurocircuitry",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.9,
      "evidence": "neurocircuitry of drug addiction",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Binge/intoxication",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.85,
      "evidence": "functional domains: Binge/intoxication",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Withdrawal/negative affect",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.85,
      "evidence": "functional domains: Withdrawal/negative affect",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Preoccupation/anticipation",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.85,
      "evidence": "functional domains: Preoccupation/anticipation",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Neurocircuits",
      "attributes": {
        "target_type": "pathway"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.8,
      "evidence": "neuroadaptation levels: Neurocircuits",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Synaptic systems",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.8,
      "evidence": "neuroadaptation levels: Synaptic systems",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "Molecules",
      "attributes": {
        "target_type": "process"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.8,
      "evidence": "neuroadaptation levels: Molecules",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Effect",
      "name": "compulsive-like behaviours",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "confidence": 0.9,
      "evidence": "compulsive-like behaviours underlying drug addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "basal ganglia",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.9,
      "evidence": "basal ganglia [blue]",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "extended amygdala and habenula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.9,
      "evidence": "extended amygdala and habenula [red]",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "PFC, insula, and allocortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.9,
      "evidence": "PFC, insula, and allocortex [green]",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.95,
      "evidence": "allostatic state of addiction",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Study",
      "name": "Koob and Volkow (2010)",
      "attributes": {
        "year": 2010
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.85,
      "evidence": "Modified from Koob and Volkow (2010)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Evidence",
      "name": "review",
      "attributes": {
        "evidence_level": 3
      },
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "confidence": 0.7,
      "evidence": "Modified from Koob and Volkow (2010)",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "ACC",
      "attributes": {
        "target_type": "brain_region",
        "species": "rat"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "ACC (anterior cingulate cortex)",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "PL",
      "attributes": {
        "target_type": "brain_region",
        "species": "rat"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "PL (prelimbic cortex)",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "IL",
      "attributes": {
        "target_type": "brain_region",
        "species": "rat"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "IL (infralimbic cortex)",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "OFC",
      "attributes": {
        "target_type": "brain_region",
        "species": "rat"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "OFC (orbitofrontal cortex)",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "INS",
      "attributes": {
        "target_type": "brain_region",
        "species": "rat"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "INS (insula)",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "ACC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "ACC",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "dlPFC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "dlPFC (dorsolateral prefrontal cortex)",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "vlPFC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "vlPFC (ventrolateral prefrontal cortex)",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "vmPFC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "vmPFC (ventromedial prefrontal cortex)",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "OFC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "OFC",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "DS",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "DS (dorsal striatum)",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "GP",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "GP (globus pallidus)",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "Thalamus",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "Thalamus",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "NAc",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "NAc (nucleus accumbens)",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "BNST",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "BNST (bed nucleus of the stria terminalis)",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Target",
      "name": "CeA",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "CeA (central nucleus of the amygdala)",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Target",
      "name": "HPC",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "HPC (hippocampus)",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Target",
      "name": "Insula",
      "attributes": {
        "target_type": "brain_region",
        "species": "human"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "Insula",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Effect",
      "name": "Stimulus value Action value/cost",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.8,
      "evidence": "'Stimulus value Action value/cost'",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "Anticipation/availability Context",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.8,
      "evidence": "'Anticipation/availability Context'",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Effect",
      "name": "Action inhibition Emotion control",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.8,
      "evidence": "'Action inhibition Emotion control'",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Effect",
      "name": "Outcome valuation Drug subjective value",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.8,
      "evidence": "'Outcome valuation Drug subjective value'",
      "verified": true
    },
    {
      "id": "E23",
      "type": "Effect",
      "name": "Affective state",
      "attributes": {
        "level": "systemic",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.7,
      "evidence": "resulting 'Affective state'",
      "verified": true
    },
    {
      "id": "E24",
      "type": "Effect",
      "name": "Stress",
      "attributes": {
        "level": "systemic",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.7,
      "evidence": "'Stress'",
      "verified": true
    },
    {
      "id": "E25",
      "type": "Effect",
      "name": "Incentive to action",
      "attributes": {
        "level": "behavioral",
        "valence": "neutral"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.7,
      "evidence": "'Incentive to action'",
      "verified": true
    },
    {
      "id": "E26",
      "type": "Condition",
      "name": "addiction",
      "attributes": {
        "condition_type": "disorder"
      },
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "confidence": 0.9,
      "evidence": "neurobiological basis of addiction",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Dopamine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Dopamine15Increase",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Opioid peptides",
      "attributes": {
        "target_type": "peptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Opioid peptides16Increase",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Serotonin",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Serotonin17Increase",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "Gamma-aminobutyric acid",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "gamma-aminobutyric acid18Increase",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Acetylcholine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Acetylcholine19Increase",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Corticotropin-releasing factor",
      "attributes": {
        "target_type": "hormone"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Corticotropin-releasing factor20Increase",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Dynorphin",
      "attributes": {
        "target_type": "peptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Dynorphin21Increase",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "Norepinephrine",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Norepinephrine22Increase",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "Hypocretin (orexin)",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Hypocretin (orexin)23Increase",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "Substance P",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Substance P24Increase",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Target",
      "name": "Neuropeptide Y",
      "attributes": {
        "target_type": "neuropeptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Neuropeptide Y27Decrease",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Target",
      "name": "Nociceptin",
      "attributes": {
        "target_type": "peptide"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Nociceptin28Decrease",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Target",
      "name": "Endocannabinoids",
      "attributes": {
        "target_type": "lipid"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Endocannabinoids29Decrease",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Target",
      "name": "Oxytocin",
      "attributes": {
        "target_type": "hormone"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Oxytocin30Decrease",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Target",
      "name": "Glutamate",
      "attributes": {
        "target_type": "neurotransmitter"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.9,
      "evidence": "Glutamate32Increase",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Effect",
      "name": "Increase in neurochemical levels",
      "attributes": {
        "level": "molecular",
        "valence": "positive"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.8,
      "evidence": "Increase in multiple targets",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Effect",
      "name": "Decrease in neurochemical levels",
      "attributes": {
        "level": "molecular",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "confidence": 0.8,
      "evidence": "Decrease in multiple targets",
      "verified": true
    },
    {
      "id": "E1",
      "type": "Target",
      "name": "Ventral tegmental area",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Ventral tegmental area",
      "verified": true
    },
    {
      "id": "E2",
      "type": "Target",
      "name": "Dorsal striatum",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Dorsal striatum",
      "verified": true
    },
    {
      "id": "E3",
      "type": "Target",
      "name": "Central nucleus of amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Central nucleus of amygdala",
      "verified": true
    },
    {
      "id": "E4",
      "type": "Target",
      "name": "BNST",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "BNST",
      "verified": true
    },
    {
      "id": "E5",
      "type": "Target",
      "name": "Nucleus accumbens shell",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Nucleus accumbens shell",
      "verified": true
    },
    {
      "id": "E6",
      "type": "Target",
      "name": "Habenula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Habenula",
      "verified": true
    },
    {
      "id": "E7",
      "type": "Target",
      "name": "Prefrontal cortex",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Prefrontal cortex",
      "verified": true
    },
    {
      "id": "E8",
      "type": "Target",
      "name": "Hippocampus",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Hippocampus",
      "verified": true
    },
    {
      "id": "E9",
      "type": "Target",
      "name": "Basolateral amygdala",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Basolateral amygdala",
      "verified": true
    },
    {
      "id": "E10",
      "type": "Target",
      "name": "Insula",
      "attributes": {
        "target_type": "brain region"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Insula",
      "verified": true
    },
    {
      "id": "E11",
      "type": "Compound",
      "name": "Glutamate",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.95,
      "evidence": "Glutamate",
      "verified": true
    },
    {
      "id": "E12",
      "type": "Compound",
      "name": "gamma-aminobutyric acid",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "gamma-aminobutyric acid",
      "verified": true
    },
    {
      "id": "E13",
      "type": "Compound",
      "name": "Dopamine",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.95,
      "evidence": "Dopamine",
      "verified": true
    },
    {
      "id": "E14",
      "type": "Compound",
      "name": "Corticotropin-releasing factor",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Corticotropin-releasing factor",
      "verified": true
    },
    {
      "id": "E15",
      "type": "Compound",
      "name": "Norepinephrine",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.95,
      "evidence": "Norepinephrine",
      "verified": true
    },
    {
      "id": "E16",
      "type": "Compound",
      "name": "Dynorphin",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Dynorphin",
      "verified": true
    },
    {
      "id": "E17",
      "type": "Compound",
      "name": "Acetylcholine",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.95,
      "evidence": "Acetylcholine",
      "verified": true
    },
    {
      "id": "E18",
      "type": "Compound",
      "name": "Neuropeptide Y",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.85,
      "evidence": "Neuropeptide Y",
      "verified": true
    },
    {
      "id": "E19",
      "type": "Compound",
      "name": "Endocannabinoids",
      "attributes": {},
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.9,
      "evidence": "Endocannabinoids",
      "verified": true
    },
    {
      "id": "E20",
      "type": "Effect",
      "name": "Binge/intoxication",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.8,
      "evidence": "Binge/intoxication",
      "verified": true
    },
    {
      "id": "E21",
      "type": "Effect",
      "name": "Withdrawal/negative affect",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.8,
      "evidence": "Withdrawal/negative affect",
      "verified": true
    },
    {
      "id": "E22",
      "type": "Effect",
      "name": "Preoccupation/anticipation",
      "attributes": {
        "level": "behavioral",
        "valence": "negative"
      },
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "confidence": 0.8,
      "evidence": "Preoccupation/anticipation",
      "verified": true
    }
  ],
  "relationships": [
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E4",
      "attributes": {
        "action": "activates"
      },
      "confidence": 0.8,
      "evidence": "fast and steep increases in dopamine activate low-affinity dopamine D1 receptors",
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {
        "action": "stimulates"
      },
      "confidence": 0.8,
      "evidence": "dopamine stimulation of high-affinity dopamine D2 receptors",
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "dopamine is associated with the rewarding effects",
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "fast and steep release of dopamine is associated with the subjective sensation of the so-called high",
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "triggering conditioned responses",
      "source_chunk_ids": [
        "e0f21a2c2e93cb8dfafbdc8ee8cd6625"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "acts at"
      },
      "confidence": 0.8,
      "evidence": "endocannabinoid systems that act at the level of either the ventral tegmental area",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "acts at"
      },
      "confidence": 0.8,
      "evidence": "endocannabinoid systems that act at the level of ... nucleus accumbens",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Balanced circuits result in proper inhibitory control and decision making and normal functioning",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "interoception ... contributes to the awareness of negative emotional states",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E14",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "dopamine ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "ACTS_ON",
      "source_entity_id": "E15",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "enkephalins ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E16",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "glutamate ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E17",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "gamma-aminobutyric acid ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E18",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "norepinephrine ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E19",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "corticotropin-releasing factor ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "ACTS_ON",
      "source_entity_id": "E20",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "dynorphin ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "ACTS_ON",
      "source_entity_id": "E21",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "neuropeptide Y ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "ACTS_ON",
      "source_entity_id": "E22",
      "target_entity_id": "E13",
      "attributes": {
        "action": "implicated in"
      },
      "confidence": 0.75,
      "evidence": "endocannabinoids ... implicated in these neuroadaptations",
      "source_chunk_ids": [
        "02b961084a144f8641ae306b3a30d69c"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "glutamate-modulated NMDA receptors",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "action": "modulates"
      },
      "confidence": 0.7,
      "evidence": "glutamate-modulated AMPA receptors",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E3",
      "attributes": {
        "action": "projects"
      },
      "confidence": 0.75,
      "evidence": "glutamatergic projections from the prefrontal cortex",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "action": "projects"
      },
      "confidence": 0.75,
      "evidence": "glutamatergic projections from the amygdala",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {
        "action": "projects"
      },
      "confidence": 0.75,
      "evidence": "projections to the ventral tegmental area",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {
        "action": "projects"
      },
      "confidence": 0.75,
      "evidence": "projections to the nucleus accumbens",
      "source_chunk_ids": [
        "a64d9885d1beef4197755f3cfe1be8db"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "drive dopamine signalling to maintain motivation",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "helps explain intense desire for the drug",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "helps explain compulsive use",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "drive dopamine signalling to maintain motivation",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "impairments in executive function mediated by the prefrontal cortex",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "changes in tonic dopamine cell firing result in lower but more stable dopamine levels",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "dopamine projections to the prefrontal cortex",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "D1 receptors involved in spikes in dopamine release",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cAMP signalling involved in spikes in dopamine release",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "D3 receptors associated with drug-seeking behaviour",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E17",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "co-localise in the nucleus accumbens with D1 receptors",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E18",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.75,
      "evidence": "augments progression through the addiction cycle",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "SUGGESTS",
      "source_entity_id": "E11",
      "target_entity_id": "E18",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.8,
      "evidence": "intense desire for the drug in addiction",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "SUGGESTS",
      "source_entity_id": "E12",
      "target_entity_id": "E18",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.8,
      "evidence": "compulsive use when individuals with addiction",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "SUGGESTS",
      "source_entity_id": "E14",
      "target_entity_id": "E18",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.7,
      "evidence": "impairments in executive function in addiction",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "SUGGESTS",
      "source_entity_id": "E17",
      "target_entity_id": "E18",
      "attributes": {
        "mapping_type": "interpretive"
      },
      "confidence": 0.75,
      "evidence": "drug-seeking behaviour associated with addiction",
      "source_chunk_ids": [
        "0b3e16296e87fb2a8ba80211edd49ed1"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E11",
      "attributes": {
        "context": "neuroadaptation"
      },
      "confidence": 0.7,
      "evidence": "decreases in dopaminergic transmission during drug withdrawal",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E11",
      "attributes": {
        "context": "neuroadaptation"
      },
      "confidence": 0.7,
      "evidence": "decreases in serotonergic transmission during drug withdrawal",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "context": "neuroadaptation"
      },
      "confidence": 0.75,
      "evidence": "lower striatal dopamine responses accompanied by lower self-reports",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "context": "neuroadaptation",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increases in \u03bc opioid receptor during withdrawal",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "decreases in dopaminergic transmission measured by in-vivo microdialysis",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "REPORTS",
      "source_entity_id": "E12",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.8,
      "evidence": "decreases in serotonergic transmission measured by in-vivo microdialysis",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "striatal dopamine responses are lower in brain imaging studies",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "REPORTS",
      "source_entity_id": "E13",
      "target_entity_id": "E9",
      "attributes": {
        "outcome": "observed"
      },
      "confidence": 0.85,
      "evidence": "lower self-reports of rewarding effects in brain imaging studies",
      "source_chunk_ids": [
        "79ef615183593ad961fb7fe56524db69"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "decreases in GABAergic... contribute to decreases in reward system function",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increases in NMDA glutamatergic... contribute to decreases in reward system function",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "changes in nicotinic receptor function... might contribute to decreases in reward system function",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "decreases in reward system function might persist as long-term biochemical changes",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "long-term biochemical changes contribute to acute withdrawal",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "long-term biochemical changes contribute to acute withdrawal",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "long-term biochemical changes contribute to protracted abstinence",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "long-term biochemical changes could explain loss of interest in normal rewards",
      "source_chunk_ids": [
        "ed1341abb40f0634985929f8c62b6bc8"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "CRF are dysregulated",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "dynorphin, are recruited",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "contribute to negative emotional states",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "contributes to negative emotional state",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "CRF increases anxiety-like effects",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "anxiety-like effects during drug seeking",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.85,
      "evidence": "CRF receptor antagonists block anxiety-like effects",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "ACTS_ON",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {
        "action": "blocks"
      },
      "confidence": 0.9,
      "evidence": "kappa opioid receptor antagonists block compulsive drug seeking",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {
        "action": "drives"
      },
      "confidence": 0.8,
      "evidence": "dynorphin drives decreases in dopamine release",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "action": "contributes"
      },
      "confidence": 0.75,
      "evidence": "CRF contributes to decreased dopamine release",
      "source_chunk_ids": [
        "2ef4beb34b0f74bdf90852f85ddacdfc"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "lateral habenula plays a key role in mediating and encoding aversive states",
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "habenula is one of the regions that control the decreases in dopamine neuron firing",
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "alpha 5 nicotinic acetylcholine receptors in the habenula appear to modulate aversive responses",
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "habenular alpha 2 receptors, nicotine withdrawal",
      "source_chunk_ids": [
        "d95eb418076b55fd900ea7ef054bb16b"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E7",
      "attributes": {
        "context": "decrease"
      },
      "confidence": 0.7,
      "evidence": "decreases in reward function... trigger of negative reinforcement",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E7",
      "attributes": {
        "context": "increase"
      },
      "confidence": 0.7,
      "evidence": "increases in stress function... trigger of negative reinforcement",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "context": "contributes to"
      },
      "confidence": 0.75,
      "evidence": "negative reinforcement that contributes to compulsive drug-seeking behaviour",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {
        "context": "contributes to"
      },
      "confidence": 0.75,
      "evidence": "negative reinforcement that contributes to... addiction",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {
        "context": "overactivation",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "overactivation of the habenula... can decrease reward",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E1",
      "attributes": {
        "context": "overactivation",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "overactivation of the dynorphin system... can decrease reward",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {
        "context": "decrease"
      },
      "confidence": 0.7,
      "evidence": "dynorphin system... can decrease dopamine neuron firing",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E2",
      "attributes": {
        "context": "recruitment",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "recruitment of CRF... could drive increases in stress-like states",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E2",
      "attributes": {
        "context": "recruitment",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "extrahypothalamic stress systems... could drive increases in stress-like states",
      "source_chunk_ids": [
        "deb2fd6d50b373cd47fce0e695cf710d"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuropeptide Y act in opposition to brain stress systems",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "nociceptin act in opposition to brain stress systems",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "endocannabinoids act in opposition to brain stress systems",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "buffer brain stress systems influence vulnerability to addiction",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "endocannabinoid system modulates the response to stress",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuro-adaptations in endocannabinoid system contribute to enhanced stress reactivity",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E13",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "enhanced stress reactivity might contribute to enduring aversive emotional states",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "enduring aversive emotional states might contribute to chronic relapse",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E11",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "reductions of CB1 receptors might relate to enhanced stress reactivity",
      "source_chunk_ids": [
        "4c2f609d6537ae05b3f894688fb8b4c4"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "essential to maintain goal-directed behaviour",
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "essential to maintain ... flexibility of stimulus\u2013response associations",
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "excitatory control over dopamine cell firing and dopamine release",
      "source_chunk_ids": [
        "fc19f43d25dd35e56e31d77cdb318902"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "drug-induced reinstatement is mediated",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "mediated by the circuit",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "glutamatergic projection... involved in drug-induced reinstatement",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "cue-induced reinstatement also involves a glutamatergic projection",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "stress-induced reinstatement... depends on the activation of both CRF",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "stress-induced reinstatement... depends on the activation of... norepinephrine",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "depends on... elements of the extended amygdala",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "ventral tegmental area",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "protracted abstinence... appears to involve overactive... CRF systems",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E16",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increases in activity... could be hypothesised to elicit... craving-like responses",
      "source_chunk_ids": [
        "940f726dafbcc35a15478328cba01865"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "syndrome that is characterised by excessive salience to drug-paired cues",
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "syndrome that is characterised by decreases in the responsiveness to non-drug rewards",
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "syndrome that is characterised by decreases in the ability to inhibit maladaptive behaviour",
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "frontal cortex-derived executive function disorders in addiction",
      "source_chunk_ids": [
        "5edc6f3f4e30b7c0a79884b079c9a610"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {
        "action": "related to"
      },
      "confidence": 0.8,
      "evidence": "Cravings for food, cocaine, and nicotine are also related to middle insular function",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "The insula appears to have an interoceptive function",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "providing conscious awareness of these urges",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E8",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "differential activation of the insula during craving",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E9",
      "target_entity_id": "E8",
      "attributes": {
        "action": "involves",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "hypothesised to involve CRF activation",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "reactivity of this brain region has been suggested to serve as a biomarker to help predict relapse",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "SUGGESTS",
      "source_entity_id": "E10",
      "target_entity_id": "E3",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.55,
      "evidence": "biomarker to help predict relapse",
      "source_chunk_ids": [
        "73c51868dff57ebdda07de3e0db83e97"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "associated with decreases in baseline glucose metabolism",
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "associated with impulsivity in methamphetamine abusers",
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "associated with compulsive cocaine administration",
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "SUGGESTS",
      "source_entity_id": "E3",
      "target_entity_id": "E2",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.75,
      "evidence": "reductions of D2 receptor availability in individuals with addiction",
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {
        "mapping_type": "direct"
      },
      "confidence": 0.7,
      "evidence": "Methamphetamine-dependent individuals with striatal D2 receptor availability within the normal range had better treatment outcomes",
      "source_chunk_ids": [
        "50a2df1422c2f0450f7e4a1885cca536"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroplastic changes... are triggered by molecular and cellular adaptations",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "molecular and cellular adaptations... include signal transduction mechanisms",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E10",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "molecular and cellular adaptations... include changes in gene transcription",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "activate nucleus accumbens cAMP/PKA signalling promote escalations in drug self-administration",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "activate nucleus accumbens cAMP/PKA signalling promote compulsive-like drug-seeking behaviour",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Gs/cAMP/PKA signalling pathway... constitute a critical neuroadaptation",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "critical neuroadaptation... central to the establishment and maintenance of the addicted state",
      "source_chunk_ids": [
        "769371b9de7961682b248e8d9ad143b6"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "Introduction of cAMP response element binding protein decreases the reinforcing value",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "this change plausibly contributes to withdrawal/negative affect stage-related decreases",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leave a drug-abstinent individual in an amotivational state",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "leave a drug-abstinent individual in a dysphoric state",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "leave a drug-abstinent individual in a depressed-like state",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "increasing susceptibility to anxiety-like behaviours",
      "source_chunk_ids": [
        "eac2d4d00815df876e4f929504db5714"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "animals with elevated \u0394FosB exhibit exaggerated sensitivity",
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "leading to the hypothesis that \u0394FosB might help maintain addiction",
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "histone modifications create chromatin signatures that alter splicing",
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "effect that is necessary for the expression of cocaine-induced place preference",
      "source_chunk_ids": [
        "418ba8d682ec5d56bc3cce5eac5749a2"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E5",
      "attributes": {
        "outcome": "blocks"
      },
      "confidence": 0.7,
      "evidence": "blocks cue-induced incubation reinstatement",
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E6",
      "attributes": {
        "outcome": "blocks"
      },
      "confidence": 0.7,
      "evidence": "blocks cocaine-primed reinstatement",
      "source_chunk_ids": [
        "4859ebe30c39933e8fd1c40b395a6040"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "plays a key role in"
      },
      "confidence": 0.9,
      "evidence": "plays a key role in the dendritic translation of synaptic proteins",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "plays a major role in the molecular mechanisms associated with learning and memory",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Exposure to drug and alcohol cues activates the mTORC1 pathway",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E10",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.8,
      "evidence": "blockade of the mTORC1 pathway systemically blocked the reconsolidation of cocaine memories",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E11",
      "attributes": {
        "assertion": "refutes"
      },
      "confidence": 0.8,
      "evidence": "blockade of mTORC1 in the amygdala blocked the reconsolidation of alcohol memories",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "TREATS",
      "source_entity_id": "E1",
      "target_entity_id": "E12",
      "attributes": {
        "context": "potential"
      },
      "confidence": 0.7,
      "evidence": "potential molecular target for the treatment of relapse",
      "source_chunk_ids": [
        "21dcfad4bad426be3f7d3308454425a5"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E2",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.7,
      "evidence": "affect underlying neurobiological mechanisms",
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E3",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "affects"
      },
      "confidence": 0.7,
      "evidence": "affect underlying neurobiological mechanisms",
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "predisposes"
      },
      "confidence": 0.75,
      "evidence": "implicated in vulnerability to nicotine dependence",
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {
        "outcome": "predisposes"
      },
      "confidence": 0.75,
      "evidence": "implicated in vulnerability to nicotine dependence",
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "outcome": "predisposes"
      },
      "confidence": 0.7,
      "evidence": "associated with opioid dependence",
      "source_chunk_ids": [
        "5fd3e55e9e005f4ece8f3a92f10d4e4f"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "ACTS_ON",
      "source_entity_id": "E1",
      "target_entity_id": "E3",
      "attributes": {
        "action": "protects against",
        "outcome": "protective"
      },
      "confidence": 0.8,
      "evidence": "protective against alcoholism",
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "ACTS_ON",
      "source_entity_id": "E2",
      "target_entity_id": "E3",
      "attributes": {
        "action": "protects against",
        "outcome": "protective"
      },
      "confidence": 0.8,
      "evidence": "protective against alcoholism",
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "ACTS_ON",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {
        "action": "modulates",
        "outcome": "enhanced"
      },
      "confidence": 0.75,
      "evidence": "diminished ALDH1a1 leads to enhanced alcohol consumption",
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "ACTS_ON",
      "source_entity_id": "E6",
      "target_entity_id": "E8",
      "attributes": {
        "action": "protects against",
        "outcome": "protective"
      },
      "confidence": 0.8,
      "evidence": "protective against nicotine addiction",
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "ACTS_ON",
      "source_entity_id": "E7",
      "target_entity_id": "E8",
      "attributes": {
        "action": "protects against",
        "outcome": "protective"
      },
      "confidence": 0.8,
      "evidence": "protective against nicotine addiction",
      "source_chunk_ids": [
        "cacd07d9bd808bd8fb0dfc2d132496f3"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "CRF1 receptor gene (CRHR1)...associated with",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "associated with binge drinking",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "associated with...excessive drinking",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "single-nucleotide polymorphisms (rs1876831, C allele)...associated",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E6",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "associated"
      },
      "confidence": 0.8,
      "evidence": "associated with heavy drinking",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "single-nucleotide polymorphisms...associated",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E6",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "single-nucleotide polymorphisms...associated",
      "source_chunk_ids": [
        "00e96ca7b2b3fcc47ad1214e3242b4ba"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "mutation associated with reduction",
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reduction enhanced connectivity",
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reduction enhanced learning",
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "reduction decreased anxiety",
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "SUGGESTS",
      "source_entity_id": "E1",
      "target_entity_id": "E8",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "target for neuroplasticity in anxiety",
      "source_chunk_ids": [
        "0d67099d6924894261d2a7f489ca3156"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E13",
      "attributes": {
        "action": "associated with"
      },
      "confidence": 0.7,
      "evidence": "associated with reduced activity in prefrontal cortices",
      "source_chunk_ids": [
        "45244721d265e026f5500e1179b20ff4"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "basal ganglia-driven binge/intoxication stage",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "gain incentive salience and promoting habit formation",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E9",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "promoting habit formation that fosters excessive drug seeking",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "excessive drug seeking via increases in dopamine",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E10",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "excessive drug seeking via increases in glutamate",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "binge/intoxication stage triggers opponent-process responses",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "binge/intoxication stage triggers increased brain stress",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E15",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "increased brain stress system activity",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E16",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in executive function via dysregulation of glutamatergic",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E17",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in executive function via dysregulation of GABAergic",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E18",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "deficits in executive function via dysregulation of dopaminergic",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E19",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "dysregulation of glutamatergic networks induce compulsive drug use",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E19",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "dysregulation of GABAergic networks induce compulsive drug use",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E18",
      "target_entity_id": "E19",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.65,
      "evidence": "dysregulation of dopaminergic networks induce compulsive drug use",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "prefrontal cortex-driven preoccupation/anticipation stage",
      "source_chunk_ids": [
        "eb919b91d361c5272ede4f1ae07cd064"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E1",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.85,
      "evidence": "disruptions contribute to compulsive-like behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E2",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.8,
      "evidence": "interacting circuits in which disruptions contribute",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E3",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "functional domains contribute to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E4",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "functional domains contribute to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E5",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "functional domains contribute to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E6",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroadaptation levels relate to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E7",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroadaptation levels relate to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E8",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "neuroadaptation levels relate to behaviours",
      "source_chunk_ids": [
        "75f887565e3e630f526753c5fec06a37"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "HAS_EVIDENCE",
      "source_entity_id": "E5",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.75,
      "evidence": "Modified from Koob and Volkow (2010)",
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E4",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "allostatic state of addiction",
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E1",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "basal ganglia [blue]",
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E2",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "extended amygdala and habenula [red]",
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E5",
      "target_entity_id": "E3",
      "attributes": {
        "outcome": "describes"
      },
      "confidence": 0.8,
      "evidence": "PFC, insula, and allocortex [green]",
      "source_chunk_ids": [
        "062efc8d5a2ac847d6ddeaa14f1d39da"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "REPORTS",
      "source_entity_id": "E1",
      "target_entity_id": "E19",
      "attributes": {
        "association": "functional"
      },
      "confidence": 0.7,
      "evidence": "associated with ACC",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "REPORTS",
      "source_entity_id": "E7",
      "target_entity_id": "E20",
      "attributes": {
        "association": "functional"
      },
      "confidence": 0.7,
      "evidence": "associated with dlPFC",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "REPORTS",
      "source_entity_id": "E8",
      "target_entity_id": "E20",
      "attributes": {
        "association": "functional"
      },
      "confidence": 0.7,
      "evidence": "associated with vlPFC",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "REPORTS",
      "source_entity_id": "E9",
      "target_entity_id": "E21",
      "attributes": {
        "association": "functional"
      },
      "confidence": 0.7,
      "evidence": "associated with vmPFC",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "REPORTS",
      "source_entity_id": "E10",
      "target_entity_id": "E22",
      "attributes": {
        "association": "functional"
      },
      "confidence": 0.7,
      "evidence": "associated with OFC",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E23",
      "target_entity_id": "E24",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "resulting 'Affective state', 'Stress'",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E23",
      "target_entity_id": "E25",
      "attributes": {
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "resulting 'Affective state', 'Incentive to action'",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R8",
      "type": "SUGGESTS",
      "source_entity_id": "E26",
      "target_entity_id": "E24",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "addiction process, Stress",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R9",
      "type": "SUGGESTS",
      "source_entity_id": "E26",
      "target_entity_id": "E25",
      "attributes": {
        "mapping_type": "interpretive",
        "verification_needed": true
      },
      "confidence": 0.6,
      "evidence": "addiction process, Incentive to action",
      "source_chunk_ids": [
        "dd50a9cec21af15aece220760126aacd"
      ],
      "supporting_study_ids": [],
      "verified": false
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Dopamine15Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E2",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Opioid peptides16Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Serotonin17Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E4",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "gamma-aminobutyric acid18Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E5",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Acetylcholine19Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor20Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E7",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Dynorphin21Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E8",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Norepinephrine22Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Hypocretin (orexin)23Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E10",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Substance P24Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E1",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Dopamine25Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Serotonin17Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E11",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Neuropeptide Y27Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E12",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Nociceptin28Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E13",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Endocannabinoids29Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E14",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Oxytocin30Decrease",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E15",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate32Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E9",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Hypocretin (orexin)23Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E3",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Serotonin17Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E6",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor33Increase",
      "source_chunk_ids": [
        "a4a808a0098a1ef141cb969f8a88eb32"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R1",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate Ventral tegmental area (circuit 1)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R2",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "gamma-aminobutyric acid Ventral tegmental area (circuit 2)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R3",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "gamma-aminobutyric acid Dorsal striatum (circuit 3)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R4",
      "type": "PRODUCES",
      "source_entity_id": "E13",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Dopamine Dorsal striatum (circuit 4)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R5",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E20",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate Ventral tegmental area (circuit 5)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R6",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor Central nucleus of amygdala (circuit 6)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R7",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor BNST (circuit 7)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R8",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Norepinephrine Nucleus accumbens shell (circuit 8)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R9",
      "type": "PRODUCES",
      "source_entity_id": "E16",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Dynorphin Habenula (circuit 9)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R10",
      "type": "PRODUCES",
      "source_entity_id": "E17",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Acetylcholine Central nucleus of amygdala (circuit 10)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R11",
      "type": "PRODUCES",
      "source_entity_id": "E18",
      "target_entity_id": "E21",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Neuropeptide Y Central nucleus of amygdala (circuit 11)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R12",
      "type": "PRODUCES",
      "source_entity_id": "E19",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Endocannabinoids Preoccupation/anticipation",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R13",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate Prefrontal cortex (circuit 12)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R14",
      "type": "PRODUCES",
      "source_entity_id": "E12",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "gamma-aminobutyric acid Prefrontal cortex (circuit 13)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R15",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate Hippocampus (circuit 14)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R16",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate Basolateral amygdala (circuit 15)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R17",
      "type": "PRODUCES",
      "source_entity_id": "E11",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Glutamate BNST (circuit 16)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R18",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor BNST (circuit 17)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R19",
      "type": "PRODUCES",
      "source_entity_id": "E15",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Norepinephrine Insula (circuit 18)",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    },
    {
      "id": "R20",
      "type": "PRODUCES",
      "source_entity_id": "E14",
      "target_entity_id": "E22",
      "attributes": {},
      "confidence": 0.7,
      "evidence": "Corticotropin-releasing factor",
      "source_chunk_ids": [
        "e0db66b38d58fb644154fa6eb5980ad7"
      ],
      "supporting_study_ids": [],
      "verified": true
    }
  ]
}